F-group (family)

10.32.1.2 F5_F8_type_C

Ligands and drugs

606
Member domains
223
with ligand contacts (≤ 4 Å)
36.8% of members
199
with DrugDomain annotations
32.8% of members
89
with a DrugBank compound
14.7% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 10.32.1.2 belongs to X-group 10 jelly-roll, which binds 8.5 ligand superclasses per 20 proteins, broader than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine7
DB00563MTXMethotrexate7
DB020421PG2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol5
DB12010—Fostamatinib2
DB00133SERSerine1
DB01985AAGN-acetyl-L-arginine1
DB03567A2Galpha-N-Acetyl-D-galactosamine1
DB03709BCNBicine1
DB03974HRGL-homoarginine1
DB04522SEPDexfosfoserine1
DB08896——1
DB15822—Pralsetinib1

Most frequently bound compounds

PDB ligandNameDomains in contact
CAmetalCALCIUM ION88
NAmetalSODIUM ION42
GALbeta-D-galactopyranose11
ZNmetalZINC ION9
NAG2-acetamido-2-deoxy-beta-D-glucopyranose8
MGmetalMAGNESIUM ION7
NImetalNICKEL (II) ION6
1PG2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL5
AR5N~2~-(tert-butoxycarbonyl)-L-arginine4
CLCHLORIDE ION4
MRD(4R)-2-METHYLPENTANE-2,4-DIOL4
MTXMETHOTREXATE4
8DR(S)-2-(3-(benzo[c][1,2,5]thiadiazole-4-sulfonamido)thiophene-2-carboxamido)-5-guanidinopentanoic acid2
A1IAT(2~{S})-2-[[3-[[6-[3-(aminomethyl)phenyl]quinolin-8-yl]sulfonylamino]thiophen-2-yl]carbonylamino]-5-carbamimidamido-pentanoic acid2
DUE(2~{S})-2-[[3-[[5-[4-(aminomethyl)phenyl]-1-benzofuran-7-yl]sulfonylamino]thiophen-2-yl]carbonylamino]-5-carbamimidamido-pentanoic acid2
NGA2-acetamido-2-deoxy-beta-D-galactopyranose2
R40N~2~-[(benzyloxy)carbonyl]-L-arginine2
6JYN~2~-(benzenecarbonyl)-L-arginine1
6K8N-(benzenecarbonyl)glycyl-L-arginine1
768(2R)-1-(2,4-dichlorophenoxy)-3-[(2E)-2-imino-3-(2-piperidin-1-ylethyl)-2,3-dihydro-1H-benzimidazol-1-yl]propan-2-ol1